A phaseI dose escalation study of AMN107 in combination with Imatinib on a continous daily dosing schedule in adult patients with Imatinib-resistent gastrointestinal stromal tumours (GIST)

Update Il y a 4 ans
Reference: EUCTR2005-000561-18